Status:

RECRUITING

Hirschsprung's Advances; Working Towards Autologous tIssue therapIes

Lead Sponsor:

Alder Hey Children's NHS Foundation Trust

Collaborating Sponsors:

University of Liverpool

Conditions:

Hirschsprung Disease

Eligibility:

All Genders

Up to 15 years

Brief Summary

Children with Hirschsprung's Disease (HSCR) have no normal nerve cells in the lower end of their bowel. This can cause babies to die if left untreated treated. Currently the part of bowel that doesn't...

Detailed Description

The gastrointestinal (GI) tract is responsible for many functions essential to life such as digestion, absorption and excretion, all of which are under the control of its own intrinsic nervous system,...

Eligibility Criteria

Inclusion

  • • Any child undergoing therapeutic intestinal resection (but specifically those in which it is not necessary for all resected tissue to be sent for histopathological analysis, as no additional tissue will be removed for research purposes).

Exclusion

  • • None

Key Trial Info

Start Date :

March 5 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 1 2036

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT06590142

Start Date

March 5 2024

End Date

March 1 2036

Last Update

September 19 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Alder Hey Children's NHS Foundation Trust

Liverpool, Merseyside, United Kingdom, L12 2AP

Hirschsprung's Advances; Working Towards Autologous tIssue therapIes | DecenTrialz